Skip to main content

Table 8 Summary of DC vaccination and clinical responses

From: A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment

Patient DC injections
Regular (boosting)
Best response (duration)
1 4 PDa
2 2 PD
3 4 PD
4 4 PD
5 4(2) SDb (105 days)
6 4 PD
7 4 PD
8 3 PD
9 4 PD
10 4 PD
11 4 PD
12 4(1) SD (98 days)
  1. aPD: progressive disease
  2. bSD: stable disease